Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Trends 2025–2029: Regional Outlook and Sizing Analysis
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
#How Much Will The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Be Worth By 2029?#_x000D_
With the rapid expansion seen in recent times, the size of the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market is projected to rise from $49.32 billion in 2024 to $54.73 billion in 2025, with a compound annual growth rate (CAGR) of 11.0%. This growth observed in the historic period is credited to factors such as an increase in pharmaceutical outsourcing, the growing intricacy of drug formulations, cost-cutting initiatives taken by pharmaceutical companies, the escalating demand for generics and biosimilars, as well as the expansion of small to mid-sized pharmaceutical firms._x000D_
_x000D_
The market size for the pharmaceutical contract development and manufacturing organization (CDMO) for formulations is projected to experience swift expansion in the upcoming years, surging to a value of $82.15 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. This acceleration in growth during the forecast period can be traced back to an increase in biologics and advanced treatment options, advancement in personalized medicine, the rising emphasis on continuous manufacturing, regulatory support for outsourcing, increased digitalization, and the incorporation of automation in manufacturing practices. Foreseen trends within the forecast duration entail increased continuous manufacturing, the application of AI and machine learning in drug creation, development of high-potency API (HPAPI) handling capabilities, an increased emphasis on biologics and complex injectable formulations, and a growing drive towards sustainable and environmentally friendly manufacturing methods._x000D_
_x000D_
#Get A Free Sample Of The Report:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=25876&type=smp_x000D_
_x000D_
#Which Key Factors Are Fueling Growth In The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market?#_x000D_
The pharmaceutical contract development and manufacturing organization (CDMO) for formulations market is anticipated to thrive due to an escalation in drug development and manufacturing activities. Such activities involve the heightened endeavors by pharmaceutical and biopharmaceutical corporations to investigate, create, and manufacture innovative drugs. These activities are prevalent primarily due to the surging global need for new and effective treatments, which encourages companies to extend their development endeavors and expedite manufacturing procedures. Pharmaceutical CDMOs play a pivotal role in the progression of drug development by formulating and enhancing dosage forms, conducting stability tests, and upholding regulatory compliance. They also supervise scale-up and production to enable swift, cost-effective product introductions. For example, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based association representing the pharmaceutical industry across Europe, reported total pharmaceutical production in Europe reached $422,803 million (€390,000 million), an increase from $393,857 million (€363,300 million) in 2022. Consequently, the surge in drug development and manufacturing activities are fueling the expansion of the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market._x000D_
_x000D_
#Which Segmentation Factors Are Critical In The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Analysis?#_x000D_
The pharmaceutical contract development and manufacturing organization (cdmo) for formulations market covered in this report is segmented – _x000D_
_x000D_
1) By Dosage Form: Oral Solids, Oral Liquids, Injectables, Topicals, Inhalation Products, Transdermal And Patches, Other Dosage Forms_x000D_
2) By Therapeutic Area: Oncology, Cardiology, Central Nervous System, Gastroenterology, Infectious Diseases, Endocrinology _x000D_
3) By End-User: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Oral Solids: Tablets, Capsules, Granules, Powders, Modified-Release Formulations_x000D_
2) By Oral Liquids: Syrups, Suspensions, Solutions, Emulsions, Elixirs_x000D_
3) By Injectables: Vials, Ampoules, Prefilled Syringes, Lyophilized Injections, Injectable Emulsions_x000D_
4) By Topicals: Creams, Ointments, Gels, Lotions, Foams, _x000D_
5) By Inhalation Products: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizer Solutions, Nasal Sprays, Inhalation Capsules_x000D_
6) By Transdermal And Patches: Matrix Patches, Reservoir Patches, Drug-In-Adhesive Patches, Microneedle Patches, Iontophoretic Patches_x000D_
7) By Other Dosage Forms: Suppositories, Ophthalmic Preparations, Buccal Tablets, Sublingual Tablets, Implants_x000D_
_x000D_
#What Are The Dominant Trends Currently Seen In The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market?#_x000D_
Leading businesses in the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market are making strides in producing innovative solutions like biologic formulation platforms. These platforms aim to bolster drug stability and speed up the launch process for complex biologic treatments. The biologic formulation platforms are specialized methods intended to generate stable and efficient formulations of biologic drugs, enhancing stability, bioavailability, and safety throughout the product lifecycle. For example, WuXi Biologics, a contract research, development, and manufacturing organization based in China, unveiled WuXiHigh 2.0 in June 2025. This cutting-edge platform supports biologic formulations with protein concentrations as high as 230 mg/mL, exceeding the present limit of 200 mg/mL approved by the Food and Drug Administration, while also decreasing viscosity by about 90% using proprietary excipient mixes and high-throughput devices. It tackles core obstacles in creating high-concentration biologics, including viscosity and aggregation, and is constructed to boost injection efficiency, patient adherence, and manufacturing results in both clinical and commercial phases._x000D_
_x000D_
#Which Players Are Shaping The Competitive Landscape Of The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market?#_x000D_
Major companies operating in the pharmaceutical contract development and manufacturing organization (cdmo) for formulations market are Thermo Fisher Scientific Inc., Lonza Group, Catalent Inc., WuXi Biologics, Samsung Biologics, Recipharm AB, Siegfried Holding AG, Evonik Industries AG, Almac Group, Aenova Group, Piramal Pharma Limited, Cambrex, Jubilant Pharmova Limited, CordenPharma, Altasciences, Hovione, Aurigene Pharmaceutical Services Ltd., DPT Laboratories Ltd., CARBOGEN AMCIS, Biopharma Group, LGM Pharma, Aarti Pharmalabs Limited. _x000D_
_x000D_
#Access The Complete Report Here:#_x000D_
_x000D_
#Which Region Is Likely To Register The Fastest Growth In The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market?#_x000D_
Asia-Pacific was the largest region in the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cdmo) for formulations market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Customize Your Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=25876&type=smp_x000D_
_x000D_
Browse Through More Reports Similar to the Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market 2025, By The Business Research Company_x000D_
_x000D_
Pharmaceutical Contract Packaging Global Market Report 2025_x000D_
_x000D_
Pharmaceutical Continuous Manufacturing Global Market Report 2025_x000D_
_x000D_
Biopharmaceuticals Contract Manufacturing Global Market Report 2025_x000D_
_x000D_
#About The Business Research Company:#_x000D_
_x000D_
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
